Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology CommissionGraham Cooke, Alexandre de Araújo, Zyaad Ameen et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 539
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisRoberta D’Ambrosio, Pierre Bédossa, Alessio Aghemo et al.|Hepatology|2012Cited by 404
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Pietro Lampertico, Roberta D’Ambrosio et al.|Journal of Hepatology|2020Cited by 392
Impact of COVID-19 on global HCV elimination effortsSarah Blach, Antonio Craxı̀, Loreta A. Kondili et al.|Journal of Hepatology|2020Cited by 279
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis CMaria Grazia Rumi, Massimo Colombo, Alessio Aghemo et al.|Gastroenterology|2009Cited by 199